Allworth Financial LP Ardelyx, Inc. Transaction History
Allworth Financial LP
- $14 Billion
- Q1 2024
A detailed history of Allworth Financial LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 535 shares of ARDX stock, worth $3,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
535
Previous 476
12.39%
Holding current value
$3,964
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
197Shares Held
140MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$163 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$127 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$99.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$50.5 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $1.15B
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...